Your browser doesn't support javascript.
loading
Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn's Disease in Remission on Infliximab and Azathioprine.
Syal, Gaurav; Melmed, Gil Y; Almario, Christopher V; Spiegel, Brennan M R.
Afiliación
  • Syal G; Division of Gastroenterology, University of California at San Diego, 9452 S Medical Ctr Dr, La Jolla, San Diego, CA, 92037, USA. gsyal@health.ucsd.edu.
  • Melmed GY; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, 8730 Alden Drive, Second Floor East, Los Angeles, CA, 90048, USA.
  • Almario CV; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Pacific Theaters Building, Suite 800, 116 N. Robertson Blvd., Los Angeles, CA, 90048, USA.
  • Spiegel BMR; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Pacific Theaters Building, Suite 800, 116 N. Robertson Blvd., Los Angeles, CA, 90048, USA.
Dig Dis Sci ; 68(2): 404-413, 2023 02.
Article en En | MEDLINE | ID: mdl-36512266
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azatioprina / Enfermedad de Crohn Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Child, preschool / Humans Idioma: En Revista: Dig Dis Sci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azatioprina / Enfermedad de Crohn Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Child, preschool / Humans Idioma: En Revista: Dig Dis Sci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos